Dashboard
Manage Tickers

CVACCureVac N.V.

Nasdaq curevac.com


$ 2.98 $ 0.04 (1.36 %)    

Friday, 10-May-2024 14:38:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.75 $ -1.17 (-0.26 %)
DIA $ 394.71 $ -0.55 (-0.14 %)
SPY $ 520.56 $ -0.96 (-0.18 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 219.20 $ -0.58 (-0.26 %)
$ 2.98
$ 2.94
$ 2.91 x 100
$ 2.97 x 100
$ 2.93 - $ 3.04
$ 2.22 - $ 12.36
260,224
na
667.49M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

spirit-airlines-posts-weak-results-joins-integra-lifesciences-bowlero-and-other-big-stocks-moving-lower-on-monday
Spirit Airlines Posts Weak Results, Joins ...
05/06/2024 17:05:12

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

leerink-partners-downgrades-curevac-to-market-perform-lowers-price-target-to-4
Leerink Partners Downgrades CureVac to Mar...
04/25/2024 13:12:43

Leerink Partners analyst Mani Foroohar downgrades CureVac (NASDAQ:CVAC) from Outperform to Market Perform and lowers the pri...

Core News & Articles
CureVac Has Started The Phase 1 Part Of A ...
04/24/2024 11:20:32

https://www.curevac.com/en/curevac-announces-start-of-combined-phase-1-2-study-in-avian-influenza-h5n1-development-in-collabora...

Core News & Articles
CureVac And GSK Will End The Pandemic Prep...
04/24/2024 11:18:42

curevac-is-implementing-in-2024-an-organizational-redesign-to-streamline-structures-and-reduce-operating-costs-the-program-was-initiated-with-a-voluntary-leaver-program-to-reduce-150-position
CureVac Is Implementing In 2024 An Organiz...
04/24/2024 11:17:22

curevacs-cash-and-cash-equivalents-position-of-4025m-as-of-december-31-2023-is-expected-to-provide-cash-runway-into-q4-2025
CureVac's Cash And Cash Equivalents Positi...
04/24/2024 11:16:17

curevac-q4-sales-22600m-miss-33744m-estimate
CureVac Q4 Sales €22.600M Miss €33.744M Es...
04/24/2024 11:15:00

curevac-and-md-anderson-enter-strategic-collaboration-to-develop-novel-cancer-vaccines
CureVac And MD Anderson Enter Strategic Co...
04/16/2024 11:21:25

guggenheim-reiterates-neutral-on-curevac
Guggenheim Reiterates Neutral on CureVac
04/05/2024 13:57:32

Guggenheim analyst Evan Wang reiterates CureVac (NASDAQ:CVAC) with a Neutral.

curevac-gsk-partner-release-data-on-influenza-vaccine-study
CureVac, GSK Partner Release Data On Influ...
04/04/2024 16:18:36

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

Core News & Articles
CureVac Announces Phase 2 Interim Data fro...
04/04/2024 11:07:12

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

curevac-disclosed-ceo-alexander-zehnder-recently-purchased-50000-common-shares-of-curevac-stock
CureVac Disclosed CEO Alexander Zehnder, R...
01/17/2024 14:13:04

-SEC Filing

why-biopharmaceutical-player-curevac-shares-are-rising-today
Why Biopharmaceutical Player CureVac Share...
01/05/2024 15:31:10

CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.

Core News & Articles
CureVac Unveils Positive Phase 2 Interim D...
01/05/2024 12:08:34

why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Compugen Shares Are Trading Higher By ...
12/19/2023 18:34:55

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

why-is-covid-19-vaccine-player-curevac-stock-plummeting-today
Why Is COVID-19 Vaccine Player CureVac Sto...
12/19/2023 15:31:10

A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) ...

bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday
Bluebird Bio, Vertex Energy And Other Big ...
12/19/2023 15:19:40

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

Core News & Articles
CureVac Announces Decision Of German Feder...
12/19/2023 14:39:03

Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by BioNTech SEDecis...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION